Carisma Therapeutics Inc.

Please note: The information displayed on this page might be outdated.

Carisma Therapeutics Inc.: - CARISMA Therapeutics Inc. is a clinical stage biopharmaceutical company developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania, are autologous chimeric antigen receptor (CAR)-macrophages for the treatment of solid tumors. CARISMA Therapeutics is headquartered in Philadelphia, PA.

Sector/Industry:

Healthcare/Biotechnology

Characteristics:

Based in...

US - Middle Atlantic

Clinical Stage

Phase l or ll

Disease Space

Oncology

Listing

Private

Website:

http://carismatx.com/

Profiles:

Address:

3675 Market Street
Philadelphia, PA 19104
United States

Presentation:

Presentation at Winter Private Company Showcase
Carisma Therapeutics Inc.

Please reach out to Solebury Trout to request a presentation

More info:

Send Message to Request Information

My account:

Company Participants at Fall Private Company Showcase 2020

Steven Kelly

Carisma Therapeutics Inc., CEO

Steven Kelly joined Carisma Therapeutics in February 2018 bringing nearly thirty years of experience in Pharma/Biotech at all phases of the business across multiple therapeutic categories. Prior to joining Carisma, Mr. Kelly held a number of leadership positions in the biotechnology industry including: CEO, Pinteon Therapeutics; CEO, Theracrine; CCO, BioVex; CEO, Innovive Pharmaceuticals; as well as various commercial and manufacturing roles at Sanofi, IDEC Pharmaceuticals and Amgen. Steve holds a BS from the University of Oregon and an MBA from Cornell University.

Carisma Therapeutics Inc.

Company Participants at Fall Private Company Showcase 2020

Upcoming Company Event Participation

Spring Private Company Showcase